Artificial veins could boost success of organ transplants
Bonus Biogroup has developed microscopic biodegradable tubes that run through an engineered transplant organ, supplying a steady flow of blood.
Bonus Biogroup has developed microscopic biodegradable tubes that run through an engineered transplant organ, supplying a steady flow of blood.
Bonus Biogroup recognized as a global leader in innovation in biotechnology, cell therapy and development of effective treatments.
Bonus BioGroup’s MesenCure drug shown to lower the inflammatory overreaction in cancer patients that can cause multisystem failure.
Bonus BioGroup says its MesenCure experimental treatment resulted in 94% survival rate of trial subjects and cut hospitalization time in half.
Did you know that there’s a machine that turns air into water? And a technology that allows cars to drive on their own? It all happens in Israel!
Procedure was part of a clinical trial of human bone tissue grown in a bioreactor from fat cells of the same patient, eliminating risk of rejection.
Procedure was part of early clinical trial of human bone tissue grown in the lab from stem cells of the patient, so there’s no risk of rejection.
ISRAEL21c rounds up the top super-cool technological advances from Israeli companies that you should keep an eye on next year.
Ground broken in Haifa for revolutionary facility set to produce personalized human living bone for grafts.
Bonus Biogroup’s major breakthrough generates new healthy bone from stem cells.